Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome

Raymond Fertig, Jerry Shapiro, Wilma Bergfeld, Antonella Tosti

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Postfinasteride syndrome (PFS) is a term recently coined to characterize a constellation of reported undesirable side effects described in postmarketing reports and small uncontrolled studies that developed during or after stopping finasteride treatment, and persisted after drug discontinuation. Symptoms included decreased libido, erectile dysfunction, sexual anhedonia, decreased sperm count, gynecomastia, skin changes, cognitive impairment, fatigue, anxiety, depression, and suicidal ideation. The aim of this study is to review the existing medical literature for evidence-based research of permanent sexual dysfunction and mood changes during treatment with 5-alpha-reductase inhibitors including finasteride and dutasteride.

Original languageEnglish (US)
Pages (from-to)120-129
Number of pages10
JournalSkin Appendage Disorders
Volume2
Issue number3-4
DOIs
StatePublished - Jan 1 2016

Fingerprint

5-alpha Reductase Inhibitors
Finasteride
Anhedonia
Gynecomastia
Libido
Suicidal Ideation
Sperm Count
Erectile Dysfunction
Fatigue
Anxiety
Depression
Skin
Therapeutics
Research
Pharmaceutical Preparations

Keywords

  • Dutasteride
  • Finasteride
  • Permanent sexual dysfunction
  • Physical adverse effects
  • Psyche
  • Psychiatric adverse effects
  • Side effects

ASJC Scopus subject areas

  • Dermatology

Cite this

Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome. / Fertig, Raymond; Shapiro, Jerry; Bergfeld, Wilma; Tosti, Antonella.

In: Skin Appendage Disorders, Vol. 2, No. 3-4, 01.01.2016, p. 120-129.

Research output: Contribution to journalReview article

Fertig, Raymond ; Shapiro, Jerry ; Bergfeld, Wilma ; Tosti, Antonella. / Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome. In: Skin Appendage Disorders. 2016 ; Vol. 2, No. 3-4. pp. 120-129.
@article{a6ee439bae3548a0be44ca0d7b297189,
title = "Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome",
abstract = "Postfinasteride syndrome (PFS) is a term recently coined to characterize a constellation of reported undesirable side effects described in postmarketing reports and small uncontrolled studies that developed during or after stopping finasteride treatment, and persisted after drug discontinuation. Symptoms included decreased libido, erectile dysfunction, sexual anhedonia, decreased sperm count, gynecomastia, skin changes, cognitive impairment, fatigue, anxiety, depression, and suicidal ideation. The aim of this study is to review the existing medical literature for evidence-based research of permanent sexual dysfunction and mood changes during treatment with 5-alpha-reductase inhibitors including finasteride and dutasteride.",
keywords = "Dutasteride, Finasteride, Permanent sexual dysfunction, Physical adverse effects, Psyche, Psychiatric adverse effects, Side effects",
author = "Raymond Fertig and Jerry Shapiro and Wilma Bergfeld and Antonella Tosti",
year = "2016",
month = "1",
day = "1",
doi = "10.1159/000450617",
language = "English (US)",
volume = "2",
pages = "120--129",
journal = "Skin Appendage Disorders",
issn = "2296-9195",
publisher = "S. Karger AG",
number = "3-4",

}

TY - JOUR

T1 - Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome

AU - Fertig, Raymond

AU - Shapiro, Jerry

AU - Bergfeld, Wilma

AU - Tosti, Antonella

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Postfinasteride syndrome (PFS) is a term recently coined to characterize a constellation of reported undesirable side effects described in postmarketing reports and small uncontrolled studies that developed during or after stopping finasteride treatment, and persisted after drug discontinuation. Symptoms included decreased libido, erectile dysfunction, sexual anhedonia, decreased sperm count, gynecomastia, skin changes, cognitive impairment, fatigue, anxiety, depression, and suicidal ideation. The aim of this study is to review the existing medical literature for evidence-based research of permanent sexual dysfunction and mood changes during treatment with 5-alpha-reductase inhibitors including finasteride and dutasteride.

AB - Postfinasteride syndrome (PFS) is a term recently coined to characterize a constellation of reported undesirable side effects described in postmarketing reports and small uncontrolled studies that developed during or after stopping finasteride treatment, and persisted after drug discontinuation. Symptoms included decreased libido, erectile dysfunction, sexual anhedonia, decreased sperm count, gynecomastia, skin changes, cognitive impairment, fatigue, anxiety, depression, and suicidal ideation. The aim of this study is to review the existing medical literature for evidence-based research of permanent sexual dysfunction and mood changes during treatment with 5-alpha-reductase inhibitors including finasteride and dutasteride.

KW - Dutasteride

KW - Finasteride

KW - Permanent sexual dysfunction

KW - Physical adverse effects

KW - Psyche

KW - Psychiatric adverse effects

KW - Side effects

UR - http://www.scopus.com/inward/record.url?scp=85050125853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050125853&partnerID=8YFLogxK

U2 - 10.1159/000450617

DO - 10.1159/000450617

M3 - Review article

AN - SCOPUS:85050125853

VL - 2

SP - 120

EP - 129

JO - Skin Appendage Disorders

JF - Skin Appendage Disorders

SN - 2296-9195

IS - 3-4

ER -